Shenzhen - Delayed Quote CNY
Jinhe Biotechnology CO., LTD. (002688.SZ)
6.23
+0.05
+(0.81%)
At close: 3:04:42 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Changxian Xie | GM & Director | -- | -- | 1962 |
| Mr. You Shan Niu | Financial Director | -- | -- | 1971 |
| Mr. Zhi Jun Wang | Deputy GM & Director | -- | -- | 1974 |
| Ms. Yueqing Wang | Deputy GM & Non-Independent Director | -- | -- | 1974 |
| Mr. Manman Lu | Board Secretary & Director | -- | -- | 1973 |
| Mr. Zhi Sheng Wang | Deputy General Manager | -- | -- | 1962 |
| Mr. Ying Chun Liu | Deputy General Manager | -- | -- | 1967 |
| Mr. Yingzhen Guan | Deputy General Manager | -- | -- | 1964 |
| Lihang Zhou | Chief Accounting Officer | -- | -- | -- |
Jinhe Biotechnology CO., LTD.
1-7-2 Building 27
Zone B3 Xinghai Plaza Shahekou District
Dalian, 116023
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD. was founded in 1990 and is based in Dalian, China.
Corporate Governance
Jinhe Biotechnology CO., LTD.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 31, 2024 at 12:00 AM UTC
Ex-Dividend Date